tiprankstipranks
Arovella Therapeutics Limited (AU:ALA)
ASX:ALA

Arovella Therapeutics Limited (ALA) Share Price & Analysis

2 Followers

ALA Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.04 - AU$0.19
Previous CloseAU$0.15
Volume441.08K
Average Volume (3M)2.17M
Market Cap
AU$134.15M
Enterprise ValueAU$128.22M
Total Cash (Recent Filing)AU$6.07M
Total Debt (Recent Filing)AU$144.80K
Price to Earnings (P/E)-11.2
Beta1.14
Aug 28, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding925,156,236
10 Day Avg. Volume1,055,959
30 Day Avg. Volume2,172,761
Standard Deviation0.22
R-Squared0.00358
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

7.38%0.00%0.00%92.62%
0.00% Other Institutional Investors
92.62% Public Companies and
Individual Investors

ALA FAQ

What was Arovella Therapeutics Limited’s price range in the past 12 months?
Arovella Therapeutics Limited lowest share price was AU$0.04 and its highest was AU$0.18 in the past 12 months.
    What is Arovella Therapeutics Limited’s market cap?
    Currently, no data Available
    When is Arovella Therapeutics Limited’s upcoming earnings report date?
    Arovella Therapeutics Limited’s upcoming earnings report date is Aug 28, 2024 which is in 152 days.
      How were Arovella Therapeutics Limited’s earnings last quarter?
      Arovella Therapeutics Limited released its earnings results on Feb 28, 2024. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
        Is Arovella Therapeutics Limited overvalued?
        According to Wall Street analysts Arovella Therapeutics Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Arovella Therapeutics Limited pay dividends?
          Arovella Therapeutics Limited does not currently pay dividends.
          What is Arovella Therapeutics Limited’s EPS estimate?
          Arovella Therapeutics Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Arovella Therapeutics Limited have?
          Arovella Therapeutics Limited has 925,156,250 shares outstanding.
            What happened to Arovella Therapeutics Limited’s price movement after its last earnings report?
            Arovella Therapeutics Limited reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Arovella Therapeutics Limited?
              Currently, no hedge funds are holding shares in AU:ALA
              ---

              Company Description

              Arovella Therapeutics Limited

              Arovella Therapeutics Ltd is a biotechnology company focused on developing therapies to treat human diseases. Its two focus areas are oncology and conditions that impact the central nervous system.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Adherium Ltd.
              Island Pharmaceuticals Ltd
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis